🇺🇸 FDA
Patent

US 7157259

Murine lecithin-cholesterol acyltransferase protein

granted A61KA61K38/00A61K48/00

Quick answer

US patent 7157259 (Murine lecithin-cholesterol acyltransferase protein) held by Takeda Pharmaceutical Company Limited expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K38/00, A61K48/00